Unique Device Identification

Atlinks Acquires 5Gen Care and Chillax in Revolutionary Shift Toward Advanced AI and IoVT Technology Development

Retrieved on: 
Tuesday, January 9, 2024
Unique Device Identification, Artificial intelligence, Internet, Research, Sale, AI, Unique, UDID, Quality of life, Software, Acquisition, App Store (iOS/iPadOS), Safety, Telecommunications, Growth, Mobile phone

HONG KONG, Jan. 9, 2024 /PRNewswire/ -- Atlinks Group Limited ("Atlinks" or 'the Company"), along with its subsidiaries ('the Group"; stock code: 8043.HK), is pleased to announce that the Group has entered into the Sale and Purchase Agreements to acquire 100% issued share capital of 5Gen Care Limited and 5GenCare.com Limited ("5Gen Care"), and 100% issued share capital of Chillax Care Limited and Chillax Technology Limited ("Chillax") on 2 January 2024.

Key Points: 
  • Mr. Tong Chi Hoi, CEO of Atlinks, said, "We are excited that the acquisitions align with the Group's strategic goal of innovative technology development.
  • The acquired company, 5Gen Care and 5GenCare.com Limited, were incorporated in Hong Kong during 2020 to 2022.
  • At a commercial level, the Group is set to grow through the acquisition of 5Gen Care and Chillax, both bringing valuable assets.
  • 5Gen Care has developed reliable and secure IoVT software and has established a skilled research team in Hong Kong and Vietnam.

Atlinks Acquires 5Gen Care and Chillax in Revolutionary Shift Toward Advanced AI and IoVT Technology Development

Retrieved on: 
Tuesday, January 9, 2024
Unique Device Identification, Artificial intelligence, Internet, Research, Sale, AI, Unique, UDID, Quality of life, Software, Acquisition, App Store (iOS/iPadOS), Safety, Telecommunications, Growth, Mobile phone

HONG KONG, Jan. 9, 2024 /PRNewswire/ -- Atlinks Group Limited ("Atlinks" or 'the Company"), along with its subsidiaries ('the Group"; stock code: 8043.HK), is pleased to announce that the Group has entered into the Sale and Purchase Agreements to acquire 100% issued share capital of 5Gen Care Limited and 5GenCare.com Limited ("5Gen Care"), and 100% issued share capital of Chillax Care Limited and Chillax Technology Limited ("Chillax") on 2 January 2024.

Key Points: 
  • Mr. Tong Chi Hoi, CEO of Atlinks, said, "We are excited that the acquisitions align with the Group's strategic goal of innovative technology development.
  • The acquired company, 5Gen Care and 5GenCare.com Limited, were incorporated in Hong Kong during 2020 to 2022.
  • At a commercial level, the Group is set to grow through the acquisition of 5Gen Care and Chillax, both bringing valuable assets.
  • 5Gen Care has developed reliable and secure IoVT software and has established a skilled research team in Hong Kong and Vietnam.

Surgical Instrument Tracking System Market to grow by USD 157.17 million from 2022 to 2027, North America to account for 41% of market growth- Technavio

Retrieved on: 
Wednesday, September 20, 2023
Paragon, Unique, Spine, Securitas, Medicare, Incidence, MHealth, EHR, SE, Conditional sentence, Securitas AB, Automation, ENT, Component, Telehealth, Clinical data management, American Surgical Association, BD (company), USD, Barcode, Hardware, Growth, Centers for Medicare & Medicaid Services, RFID, Biotechnology, FREE, Koch Industries, Ulcerative colitis, Fortive, Getinge Group, Research, Complex, Case Medical Centre, UDI, Skull, Large intestine, Instrument, Colorectal cancer, ROW, Unique Device Identification, Steris, CMMS, Medical device, Retail, Dentistry, Pharmaceutical industry, Software, Geography

NEW YORK, Sept. 19, 2023 /PRNewswire/ -- The surgical instrument tracking system market is expected to grow by USD 157.17 million from 2022 to 2027.

Key Points: 
  • NEW YORK, Sept. 19, 2023 /PRNewswire/ -- The surgical instrument tracking system market is expected to grow by USD 157.17 million from 2022 to 2027.
  • In addition, the momentum of the market will progress at a CAGR of 9.34% during the forecast period, according to Technavio Research.
  • Surgical Instrument Tracking System Market: Segmentation Analysis
    The market share growth by the hardware segment will be significant during the forecast period.
  • In addition, the mandatory adoption of Unique Device Identification (UDI) regulations in surgical instrument tracking is mainly expected to drive the growth of the hardware segment in the surgical instrument tracking system market.

LEXISNEXIS® REED TECH TEAMS UP WITH REGDESK, A LEADING REGULATORY INFORMATION MANAGEMENT PLATFORM

Retrieved on: 
Thursday, May 25, 2023
Data management, EU, UDI, Unique, Intelligence, Reed Tech, Unique Device Identification, RIMS, AI, FDA, Medtech, Medical device, Cryptocurrency, HORSHAM

HORSHAM, Pa., May 25, 2023 /PRNewswire/ -- LexisNexis Legal & Professional today announced, that LexisNexis Reed Tech, provider of data management & analytic solutions for the life sciences industry, has expanded its collaboration with RegDesk, a provider of best-in-class Regulatory Information Management Systems Platform (RIMS). RegDesk offers a global submission management and regulatory intelligence platform powered by AI to provide an expedited way to prepare submissions and obtain insights into regulatory changes in over 120 countries. Current and prospective customers of both companies can effectively manage the increasing complexity of complying with ever-changing global regulations. 

Key Points: 
  • HORSHAM, Pa., May 25, 2023 /PRNewswire/ -- LexisNexis Legal & Professional today announced, that LexisNexis Reed Tech, provider of data management & analytic solutions for the life sciences industry, has expanded its collaboration with RegDesk, a provider of best-in-class Regulatory Information Management Systems Platform (RIMS).
  • RegDesk offers a global submission management and regulatory intelligence platform powered by AI to provide an expedited way to prepare submissions and obtain insights into regulatory changes in over 120 countries.
  • LexisNexis® Reed Tech teams up with RegDesk, a leading Regulatory Information Management Platform
    " RegDesk provides RIMS software that streamlines medical device registration and intelligence tracking for health authorities around the globe.
  • LexisNexis Reed Tech is expanding its collective of regulatory experts delivering solutions and services who support medical device and pharmaceutical manufacturers, distributors, and related operations.

Verizon launches new tech to monitor activity on home WiFi

Retrieved on: 
Monday, October 10, 2022
Challa, NYSE, RSS, Product management, Intelligence, Wi-Fi, Nasdaq, Awareness, Technology, Solution, Human, Unique Device Identification, Motion, Fios, Device, GLOBE, VZ, Mobile phone, Cable television, Verizon Communications

Home Awareness uses WiFi sensing technology to detect motion and report activity in your home via the My Fios App.

Key Points: 
  • Home Awareness uses WiFi sensing technology to detect motion and report activity in your home via the My Fios App.
  • Verizon and Origin Wireless will continue working together to enhance the in-home experience with additional features based on this Wi-Fi sensing technology.
  • When using Home Awareness, customers can see activity reported in the My Fios App through a live dashboard and historical views.
  • Headquartered in New York City and with a presence around the world, Verizon generated revenues of $133.6 billion in 2021.

United States Digital Therapeutics Market Trends/Analysis Report 2022-2030 - ResearchAndMarkets.com

Retrieved on: 
Friday, August 26, 2022
Technology, Health Technology, Health, Wearables, Mobile Technology, Partnership, UDI, CVS, COVID-19, Public health, Conditional sentence, Opioid use disorder, Diabetes, Digital, Therapy, Employment, Single-frequency network, Unique Device Identification, Solution, Disease, Self-management, Incidence, USD, Adolescence, Depression, Psychosis, Patient, Lists of diseases, FDA, Providers, CAGR, Growth, Adoption, Medical device, Pharmaceutical industry, Health insurance, Pear, Obesity

The "U.S. Digital Therapeutics Market Size, Share & Trends Analysis Report by Application (Diabetes, Obesity, CNS Diseases, Others), by End Use (Patients, Providers, Payers, Employers, Others), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "U.S. Digital Therapeutics Market Size, Share & Trends Analysis Report by Application (Diabetes, Obesity, CNS Diseases, Others), by End Use (Patients, Providers, Payers, Employers, Others), and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.
  • Growing healthcare consumerism, the availability & development of DTx products, and the rising number of market players are driving the regional market.
  • SparkRx by Limbix Health, for example, is a digital therapeutic that is indicated for the treatment of adolescent depression.
  • The digital therapeutics market in the U.S. was valued at USD 1.5 billion in 2021 and is expected to advance at a CAGR of 24.8% during the forecast period.

Why Medical Device QMS and UDI Data Quality Matters, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Tuesday, July 19, 2022
US FDA, CEO, Solution, ISO, Reed Tech, Unique Device Identification, Food, Medical device, QMS, UDI, Industry, State, Unique, Quality management system, QSR

TORONTO, July 19, 2022 /PRNewswire-PRWeb/ -- Are companies ready when product data is requested? Is the current version stored in an excel workbook — a hard copy in a filing cabinet or residing on a PC with a team member? When data is needed, the integrity and curation process become important. Just storing product data is not enough. It is time to leverage a medical device QMS (Quality Management System) and improve product data quality.

Key Points: 
  • In this free webinar, attendees will learn the importance of medical device product data quality to downstream stakeholders, including Unique Device Identification (UDI), Quality Management System (QMS) implementation and associated 'best practices'.
  • It is time to leverage a medical device QMS (Quality Management System) and improve product data quality.
  • In addition, the Unique Device Identification (UDI) data submitted to global health authorities forms a key component in communicating product data to downstream users.
  • For more information, or to register for this event, visit Why Medical Device QMS and UDI Data Quality Matters.

Global Surgical Instrument Tracking Systems Market Report: Growing Markets in $400+ Million Industry with Focus on North America and Asia Pacific - ResearchAndMarkets.com

Retrieved on: 
Wednesday, June 22, 2022
Surgery, Hardware, Health, Technology, Software, Sterilization, CAGR, FDA, Unique Device Identification, COVID-19, Hardware, Government, Growth, UDI, Percussion section, Adoption, Hospital, Quality Software Services, USD, RFID, Public, Scanner, Unique, Component, Medical device, Barcode, Software, Technology

Based on technology, the surgical instrument tracking systems market is segmented into barcode and RFID.

Key Points: 
  • Based on technology, the surgical instrument tracking systems market is segmented into barcode and RFID.
  • The low installation cost of barcodes has resulted in their increased adoption in the surgical instrument tracking systems market.
  • Based on components, the surgical instrument tracking systems market is segmented into software, hardware, and services.
  • Asia-Pacific: Surgical Instrument Tracking Systems Market, by Technology (2020)
    Surgical Instrument Tracking Systems Market: Geographic Growth Opportunities
    Surgical Instrument Tracking Systems Market: Developed Vs.

Allmed becomes the first fully MDR compliant haemodialysis product producer in Europe, the Middle East and Africa (EMEA) region

Retrieved on: 
Wednesday, June 15, 2022
Solution, Unique Device Identification, Safety, Notified body, MDR, BSI, Achievement, Compliance, Quality management system, UDI, Medical device, Medical device regulation, Health, BS, EMEA, Dialysis, QMS, Patient, Group, Certification, EU, MDD

With the certification, Allmed has become the first haemodialysis products producer in the EMEA region to accomplish and certify full MDR compliance on its medical devices.

Key Points: 
  • With the certification, Allmed has become the first haemodialysis products producer in the EMEA region to accomplish and certify full MDR compliance on its medical devices.
  • Becoming the first fully compliant haemodialysis product producer in the EMEA region is a testament to our commitment to delivering high quality, safe solutions to haemodialysis patients, and I am proud of the many months of hard work and commitment by Allmeds Total Quality Management team.
  • This achievement is a testament to their commitment to ensuring innovation remains at the forefront of their product development.
  • Allmed Group is a global producer of end-to-end haemodialysis product solutions.

PharmChem (PCHM) Announces Response To Opposition

Retrieved on: 
Wednesday, August 11, 2021
Face, CEO, Company, Review, THE, AND, Knowledge, CARD, TWO, Perspiration, Unique Device Identification, Bank account, BLUE, Board, Director, SEC, FDA, Philosophy, Management, Health insurance, Security (finance), Holding company

IN ORDER TO CONTINUE THE PERFORMANCE OF PHARMCHEM, WE HAVE URGED OUR STOCKHOLDERS TO VOTE THE WHITE PROXY CARD AND DISCARD THE BLUE PROXY CARD ENTIRELY.

Key Points: 
  • IN ORDER TO CONTINUE THE PERFORMANCE OF PHARMCHEM, WE HAVE URGED OUR STOCKHOLDERS TO VOTE THE WHITE PROXY CARD AND DISCARD THE BLUE PROXY CARD ENTIRELY.
  • The opposition says, "The business is an exceptional one: cashflow generative, capital light, and growing."
  • The current management and Board are the reasons PharmChem has prospered and will continue to do so if the opposition slate is defeated.Otherwise, the Company will not prosper.The inexperience of the opposition coupled with their objective to attack our cash will not benefit our stockholders.
  • Our Company has been operating virtually for many years, long before it became the norm.Where we live has not affected the success of PharmChem.